Related Experiment Video
Updated: Jan 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
RNA vaccines for cancer: revolutionizing immunization strategies
Di Huang1, Jiahui Zhang1, Xin Zeng1
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China; Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Abstract:
Cancer vaccines have emerged as a promising strategy in cancer immunotherapy, capable of eliciting robust antitumor immune responses by targeting tumor-associated antigens or tumor-specific antigens. Among the various vaccine platforms, RNA-based vaccines have garnered substantial attention, especially in light of the success of mRNA vaccines during the COVID-19 pandemic. This review outlines the fundamental characteristics of different RNA vaccine modalities, summarizes recent clinical applications in cancer treatment, and highlights strategies aimed at improving their efficacy and safety. Furthermore, we discuss the current challenges facing RNA vaccine development and offer perspectives on future directions in this rapidly advancing field.
Insights
RNA vaccines show promise for cancer immunotherapy by targeting tumor antigens. This review covers RNA vaccine types, clinical uses, and strategies to enhance their effectiveness and safety in cancer treatment.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer vaccines represent a key advance in immunotherapy, stimulating immune responses against tumor antigens.
- RNA-based vaccines, particularly mRNA technology, have gained prominence following their success in infectious disease control.
Purpose of the Study:
- To review RNA vaccine platforms for cancer immunotherapy.
- To summarize current clinical applications and future directions in RNA cancer vaccine development.
Main Methods:
- Literature review of RNA vaccine modalities.
- Analysis of clinical trial data and research publications.
- Synthesis of strategies for improving RNA vaccine efficacy and safety.
Main Results:
- RNA vaccines offer a versatile platform for cancer treatment by targeting specific antigens.
- Recent clinical studies demonstrate the potential of RNA vaccines in various cancer types.
- Ongoing research focuses on optimizing delivery, immunogenicity, and safety profiles.
Conclusions:
- RNA vaccines are a rapidly evolving and promising area of cancer immunotherapy.
- Further research and development are crucial to overcome challenges and realize the full potential of RNA cancer vaccines.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Vaccinations
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics

